1. Home
  2. KNSL vs TECH Comparison

KNSL vs TECH Comparison

Compare KNSL & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSL
  • TECH
  • Stock Information
  • Founded
  • KNSL 2009
  • TECH 1976
  • Country
  • KNSL United States
  • TECH United States
  • Employees
  • KNSL N/A
  • TECH N/A
  • Industry
  • KNSL Property-Casualty Insurers
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KNSL Finance
  • TECH Health Care
  • Exchange
  • KNSL Nasdaq
  • TECH Nasdaq
  • Market Cap
  • KNSL 10.9B
  • TECH 9.9B
  • IPO Year
  • KNSL 2016
  • TECH 1989
  • Fundamental
  • Price
  • KNSL $389.13
  • TECH $61.03
  • Analyst Decision
  • KNSL Buy
  • TECH Buy
  • Analyst Count
  • KNSL 9
  • TECH 13
  • Target Price
  • KNSL $494.88
  • TECH $70.58
  • AVG Volume (30 Days)
  • KNSL 289.8K
  • TECH 1.7M
  • Earning Date
  • KNSL 10-23-2025
  • TECH 11-05-2025
  • Dividend Yield
  • KNSL 0.17%
  • TECH 0.52%
  • EPS Growth
  • KNSL 16.09
  • TECH N/A
  • EPS
  • KNSL 20.35
  • TECH 0.46
  • Revenue
  • KNSL $1,802,839,000.00
  • TECH $1,219,635,000.00
  • Revenue This Year
  • KNSL $19.18
  • TECH $3.64
  • Revenue Next Year
  • KNSL $8.03
  • TECH $7.59
  • P/E Ratio
  • KNSL $19.10
  • TECH $133.17
  • Revenue Growth
  • KNSL 18.10
  • TECH 5.23
  • 52 Week Low
  • KNSL $382.90
  • TECH $46.01
  • 52 Week High
  • KNSL $531.79
  • TECH $80.80
  • Technical
  • Relative Strength Index (RSI)
  • KNSL 32.49
  • TECH 50.82
  • Support Level
  • KNSL $382.90
  • TECH $60.48
  • Resistance Level
  • KNSL $435.40
  • TECH $62.95
  • Average True Range (ATR)
  • KNSL 15.52
  • TECH 1.94
  • MACD
  • KNSL -7.05
  • TECH -0.54
  • Stochastic Oscillator
  • KNSL 7.77
  • TECH 19.32

About KNSL Kinsale Capital Group Inc.

Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: